Press Releases - 2023-09-08

Date	Title	Company
08-Sep-2023	Akiram Therapeutics to present promising data on the therapeutic potential of its drug candidate at EANM Congress	Akiram Therapeutics
08-Sep-2023	Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague	FluoGuide
08-Sep-2023	Discovery Park welcomes decision to re-join EU Horizon science programme	Discovery Park
08-Sep-2023	Myricx Enters into Antibody License Agreement with Biocytogen	Myricx Bio
08-Sep-2023	Rosecliff Stockholders Approve Business Combination with Spectral MD at Special Meeting	Spectral MD
08-Sep-2023	Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury	Neuroplast
08-Sep-2023	NHS releases report on dependency forming medicines	NHS Business Service Authority
08-Sep-2023	Independent pharmacy owner Olivier Picard provides Wegovy to the first patient in the UK with the support of Pharmadoctor	Pharmadoctor
08-Sep-2023	ABPI response: UK joins Horizon Europe	ABPI
08-Sep-2023	UK MHRA grants approval of Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease	MHRA
08-Sep-2023	Actimed Therapeutics announces FDA approval of its Investigational New Drug application for Phase 2b/3 IMPACT clinical trials of S-pindolol benzoate to treat cancer cachexia	Actimed Therapeutics
08-Sep-2023	Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer	Ariceum Therapeutics
08-Sep-2023	Wegovy weight-loss drug is remarkable but doesn't treat the causes of obesity, says expert	London Medical Laboratory
08-Sep-2023	Phesi and Krystelis collaborate to launch new Diversity, Equity, and Inclusion Data Service for clinical development	Phesi
08-Sep-2023	AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02 in Treatment of Myotonic Dystrophy	AMO Pharma
08-Sep-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
08-Sep-2023	Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Market Soars to US$ 5.5 Billion by 2030: FMI Analysis	MARKITWIRED
08-Sep-2023	Infection Control Revolution: The Rise of Medical Face Shields Market is expected to reach US$ 1.64 Billion by the end of 2030	MARKITWIRED
08-Sep-2023	Exploring the Future: Predicted Worth of Respiratory Pathogen Testing Kits Market at US$ 7136.8 Million by 2033	MARKITWIRED
08-Sep-2023	Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update	Adrenomed AG